BioSpace News Archive

The Lupus Research Alliance, the world’s leading research organization dedicated to lupus research, continues to watch rapidly changing developments regarding COVID-19 and is closely monitoring the policies and actions of the federal government, healthcare agencies, medical organizations and the pharmaceutical industry on behalf of people with lupus.

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent article that examines the role of artificial intelligence in pharmacovigilance.

Immunovia AB (publ) (“Immunovia”) announced today that current Board Member, Hans Johansson, has acquired Immunovia shares for 500 KSEK on the open market and his total holding is now 28542 shares.

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, today announces submission for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its IgG/IgM antibody SARS-CoV-2 rapid test detection kit.

American Lung Association shares guidance for those with asthma, COPD, lung cancer and other lung diseases

Microbiologists have long adopted the language of human settlement to describe how bacteria live and grow.

Researchers at The Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools and diagnostic capabilities.

The country’s many centers of research excellence will now be centrally linked to speed efforts to combat the pandemic

ScitoVation, a solution leader recognized as industry experts in cell-based assays and computational methods announced today the launch of a partnership with BioPredic International, a contract services, research and life sciences tools provider based in France.

As COVID-19 spreads in the Pacific Northwest, health systems have been met with a severe shortage of tests needed to keep up with demand.